Locations:
Search IconSearch

Tag: lymphoma

viral-induced cancer
April 3, 2024/Cancer

Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Treating older patients with diffuse large B-cell lymphoma (DLBCL)
January 18, 2024/Cancer/Blood Cancers

Trial for Patients 75 and Older with Diffuse Large B-Cell Lymphoma Helps Address Care Inequities

Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients

Dr. Caimi
December 15, 2023/Cancer/Research

CAR-T Cell Therapy Effective in Refractory Double-Hit/Triple-Hit Lymphoma

Two thirds of patients responded to CAR T-cell therapy

23-CNR-4221120 ASH 2023 Graphics-CQD
December 4, 2023/Cancer/Blood Cancers

Ten ASH Presentations You Don’t Want to Miss

Cleveland Clinic oncologists’ selected abstracts

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-CNR-3035899-CQD-Hero-650×450-3-ASCO2022 (new)
June 22, 2022/Cancer/Research

Top Abstracts from ASCO 2022

Notable research chosen by Cleveland Clinic Cancer Center staff

DLBCL-HE-40x_650x450
April 14, 2016/Cancer/Blood Cancers

Targeted Treatments Take Aim at Diffuse Large B Cell Lymphoma

Genetic analysis aids classification, therapeutic decisions

Figure-1_690x380
June 22, 2015/Cancer/Research

A Potential New Treatment for Aggressive Lymphomas

More efficient, safer therapy may be on horizon

BackPage 1 of 1Next

Advertisement

Ad